GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » AlzChem Group AG (XTER:ACT) » Definitions » Other Long-Term Liabilities

AlzChem Group AG (XTER:ACT) Other Long-Term Liabilities : €173.0 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is AlzChem Group AG Other Long-Term Liabilities?

AlzChem Group AG's other long-term liabilities for the quarter that ended in Mar. 2024 was €173.0 Mil.

AlzChem Group AG's quarterly other long-term liabilities declined from Sep. 2023 (€165.4 Mil) to Dec. 2023 (€26.2 Mil) but then increased from Dec. 2023 (€26.2 Mil) to Mar. 2024 (€173.0 Mil).

AlzChem Group AG's annual other long-term liabilities declined from Dec. 2021 (€28.6 Mil) to Dec. 2022 (€22.5 Mil) but then increased from Dec. 2022 (€22.5 Mil) to Dec. 2023 (€26.2 Mil).


AlzChem Group AG Other Long-Term Liabilities Historical Data

The historical data trend for AlzChem Group AG's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzChem Group AG Other Long-Term Liabilities Chart

AlzChem Group AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AlzChem Group AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AlzChem Group AG Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


AlzChem Group AG Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of AlzChem Group AG's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


AlzChem Group AG (XTER:ACT) Business Description

Traded in Other Exchanges
Address
Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
AlzChem Group AG is an international chemical company. Its reportable segments are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.

AlzChem Group AG (XTER:ACT) Headlines

From GuruFocus

Enact to Host Second Quarter 2022 Earnings Call August 2nd

By GuruFocusNews GuruFocusNews 07-08-2022

Enact Releases 2023 Environmental, Social, and Governance (ESG) Roadmap

By Stock market mentor Stock market mentor 01-26-2023

Enact to Host Fourth Quarter 2022 Earnings Call February 7th

By GlobeNewswire GlobeNewswire 01-06-2023

Enact to Host Fourth Quarter 2022 Earnings Call February 7th

By Stock market mentor Stock market mentor 01-06-2023

Enact Announces Quarterly Dividend

By sperokesalga sperokesalga 02-09-2023

Enact Receives Ratings Upgrade from Fitch Ratings

By sperokesalga sperokesalga 04-25-2023

Enact Announces an Increase to Quarterly Dividend

By sperokesalga sperokesalga 05-01-2023

Enact Receives Ratings Upgrade from S&P Global Ratings

By sperokesalga sperokesalga 02-16-2023